Nomura Holdings Inc Bristol Myers Squibb CO Put Options Transaction History

Nomura Holdings Inc

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.01 Million - $1.32 Million	25,000 Added 62.5%	65,000 $2.7 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $1.92 Million - $2.18 Million	40,000 New	40,000 $2.17 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $2.42 Million - $2.89 Million	-50,000 Reduced 55.56%	40,000 $2.05 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $5.73 Million - $6.37 Million	90,000 New	90,000 $5.76 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $9.54 Million - $11.2 Million	-174,100 Reduced 79.28%	45,500 $2.6 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $13.3 Million - $19.3 Million	-285,900 Reduced 56.56%	219,600 $12 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $14.7 Million - $19.1 Million	298,100 Added 143.73%	505,500 $31.2 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $4.28 Million - $5.07 Million	-100,000 Reduced 32.53%	207,400 $10.4 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $42.6 Million - $47.1 Million	-955,300 Reduced 75.66%	307,400 $14.2 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $48.6 Million - $58 Million	1,077,700 Added 582.54%	1,262,700 $59.6 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $10.2 Million - $11.8 Million	185,000	185,000 $11.7 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.